{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:19:16Z","timestamp":1783693156260,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Polymicrobial infections with\n                    <jats:italic>Acinetobacter baumannii (A. baumannii)<\/jats:italic>\n                    and\n                    <jats:italic>Candida albicans<\/jats:italic>\n                    (\n                    <jats:italic>C. albicans<\/jats:italic>\n                    ) are increasingly frequent in urinary tract infections (UTIs). However, experimental data describing their interactions in clinical isolates under co-culture conditions remain limited. In this study, three clinical isolates of both\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    and\n                    <jats:italic>C. albicans<\/jats:italic>\n                    were co-isolated from urine samples with UTIs, then mono-cultured and co-cultured at 24, 48, and 72 h for biofilm quantification by crystal violet assay. The expression levels of bacterial (\n                    <jats:italic>ompA, bap, abaI<\/jats:italic>\n                    ) and fungal (\n                    <jats:italic>ALS3, HWP1, ERG11<\/jats:italic>\n                    ) virulence genes were evaluated by RT-qPCR at 24 and 48 h. Co-culture conditions resulted in increased biofilm biomass compared to monoculture for the tested isolates. In\n                    <jats:italic>A. baumannii,<\/jats:italic>\n                    the virulence genes of\n                    <jats:italic>bap, abaI, and ompA<\/jats:italic>\n                    showed statistically significant increase in expression in co-culture compared to mono-culture after 24 h. In\n                    <jats:italic>C. albicans<\/jats:italic>\n                    ,\n                    <jats:italic>HWP1<\/jats:italic>\n                    is the only virulence gene that shows a statistically significant increase in expression in co-culture compared to monoculture after 48 h. Gene expression patterns varied in patient isolates, suggesting strain heterogeneity. This is an exploratory study that provides evidence of changes in biofilm formation and virulence gene expression in co-culture conditions among clinical isolates of\n                    <jats:italic>A. baumannii<\/jats:italic>\n                    and\n                    <jats:italic>C. albicans<\/jats:italic>\n                    . These findings suggest potential for microbial interactions under polymicrobial conditions, which might affect the diagnosis and treatment of patients with UTIs. Future studies with a larger number of isolates and functional assays are required to clarify the mechanistic regulation and biological relevance of these observations in UTIs.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-59824-w","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T12:55:35Z","timestamp":1783688135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory analysis of biofilm formation and virulence gene expression in Acinetobacter baumannii\u2013Candida albicans co-cultured isolates from urinary tract infections"],"prefix":"10.1038","volume":"16","author":[{"given":"Bassant","family":"Hossam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refaat M.","family":"Gabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Amr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazem H.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"59824_CR1","doi-asserted-by":"publisher","first-page":"e00652","DOI":"10.1128\/IAI.00652-20","volume":"89","author":"JR Gaston","year":"2021","unstructured":"Gaston, J. R., Johnson, A. O., Bair, K. L., White, A. N. & Armbruster, C. E. Polymicrobial interactions in the urinary tract: Is the enemy of my enemy my friend?. Infect. Immun. 89, e00652-e720 (2021).","journal-title":"Infect. Immun."},{"key":"59824_CR2","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1016\/j.jmb.2016.05.006","volume":"428","author":"WH Tay","year":"2016","unstructured":"Tay, W. H., Chong, K. K. L. & Kline, K. A. Polymicrobial-host interactions during infection. J. Mol. Biol. 428, 3355\u20133371 (2016).","journal-title":"J. Mol. Biol."},{"key":"59824_CR3","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1007\/s00345-019-03071-4","volume":"38","author":"R \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk, R. & Murt, A. Epidemiology of urological infections: A global burden. World J. Urol. 38, 2669\u20132679 (2020).","journal-title":"World J. Urol."},{"key":"59824_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman, B. Urinary tract infection syndromes. Infect. Dis. Clin. North Am. 28, 1\u201313 (2014).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"59824_CR5","first-page":"143","volume":"14","author":"RA Festa","year":"2025","unstructured":"Festa, R. A. et al. Pooled antibiotic susceptibility testing for polymicrobial UTI performs within CLSI validation standards. Antibiot. Basel Switz. 14, 143 (2025).","journal-title":"Antibiot. Basel Switz."},{"key":"59824_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf591","volume":"12","author":"A Jorda","year":"2025","unstructured":"Jorda, A. et al. Clinical and microbiological outcomes of critically Ill patients with monomicrobial versus polymicrobial bacterial bloodstream infections: A retrospective cohort study. Open Forum Infect. Dis. 12, ofaf591 (2025).","journal-title":"Open Forum Infect. Dis."},{"key":"59824_CR7","doi-asserted-by":"publisher","first-page":"1562687","DOI":"10.3389\/fcimb.2025.1562687","volume":"15","author":"RB Moreland","year":"2025","unstructured":"Moreland, R. B., Brubaker, L. & Wolfe, A. J. Polymicrobial urine cultures: Reconciling contamination with the urobiome while recognizing the pathogens. Front. Cell. Infect. Microbiol. 15, 1562687 (2025).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"59824_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269\u2013284 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"59824_CR9","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/pim.12084","volume":"36","author":"JI Odegaard","year":"2014","unstructured":"Odegaard, J. I. & Hsieh, M. H. Immune responses to S. chistosoma haematobium infection. Parasite Immunol. 36, 428\u2013438 (2014).","journal-title":"Parasite Immunol."},{"key":"59824_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/ja.2013.68","volume":"66","author":"K Osawa","year":"2013","unstructured":"Osawa, K., Shigemura, K., Yoshida, H., Fujisawa, M. & Arakawa, S. Candida urinary tract infection and Candida species susceptibilities to antifungal agents. J. Antibiot. (Tokyo) 66, 651\u2013654 (2013).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"59824_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0377-1237(04)80148-5","volume":"60","author":"K Lahiri","year":"2004","unstructured":"Lahiri, K., Mani, N. & Purai, S. Acinetobacter spp. as nosocomial pathogen: Clinical significance and antimicrobial sensitivity. Med. J. Armed Forces India 60, 7\u201310 (2004).","journal-title":"Med. J. Armed Forces India"},{"key":"59824_CR12","doi-asserted-by":"publisher","DOI":"10.22037\/uj.v0i0.4256","author":"R Ding","year":"2018","unstructured":"Ding, R., Li, X., Zhang, X., Zhang, Z. & Ma, X. The epidemiology of symptomatic catheter-associated urinary tract infections in the intensive care unit: A 4-year single center retrospective study. Urology J. https:\/\/doi.org\/10.22037\/uj.v0i0.4256 (2018).","journal-title":"Urology J."},{"key":"59824_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ajic.2017.08.037","volume":"46","author":"S Kumar","year":"2018","unstructured":"Kumar, S. et al. Prospective surveillance of device-associated health care\u2013associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India. Am. J. Infect. Control 46, 202\u2013206 (2018).","journal-title":"Am. J. Infect. Control"},{"key":"59824_CR14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s10096-015-2403-0","volume":"34","author":"C Fourcade","year":"2015","unstructured":"Fourcade, C., Canini, L., Lavigne, J.-P. & Sotto, A. A comparison of monomicrobial versus polymicrobial Enterococcus faecalis bacteriuria in a French University Hospital. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1667\u20131673 (2015).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"59824_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1128\/CMR.00058-07","volume":"21","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y., Seifert, H. & Paterson, D. L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538\u2013582 (2008).","journal-title":"Clin. Microbiol. Rev."},{"key":"59824_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/1040841X.2020.1843400","volume":"47","author":"NO Ponde","year":"2021","unstructured":"Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R. & Richardson, J. P. Candida albicans biofilms and polymicrobial interactions. Crit. Rev. Microbiol. 47, 91\u2013111 (2021).","journal-title":"Crit. Rev. Microbiol."},{"key":"59824_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s43094-023-00525-w","volume":"9","author":"EA Mohamed","year":"2023","unstructured":"Mohamed, E. A., Raafat, M. M., Samir Mohamed, R. & Ali, A. E. E. Acinetobacter baumannii biofilm and its potential therapeutic targets. Future J. Pharm. Sci. 9, 82 (2023).","journal-title":"Future J. Pharm. Sci."},{"key":"59824_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1099\/jmm.0.000394","volume":"66","author":"Y Sato","year":"2017","unstructured":"Sato, Y., Unno, Y., Kawakami, S., Ubagai, T. & Ono, Y. Virulence characteristics of Acinetobacter baumannii clinical isolates vary with the expression levels of omps. J. Med. Microbiol. 66, 203\u2013212 (2017).","journal-title":"J. Med. Microbiol."},{"key":"59824_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2217\/fmb.09.5","volume":"4","author":"JA Gaddy","year":"2009","unstructured":"Gaddy, J. A. & Actis, L. A. Regulation of Acinetobacter Baumannii biofilm formation. Future Microbiol. 4, 273\u2013278 (2009).","journal-title":"Future Microbiol."},{"key":"59824_CR20","doi-asserted-by":"publisher","first-page":"5598907","DOI":"10.1155\/2021\/5598907","volume":"2021","author":"F Mohammadi","year":"2021","unstructured":"Mohammadi, F., Hemmat, N., Bajalan, Z. & Javadi, A. Analysis of biofilm-related genes and antifungal susceptibility pattern of vaginal Candida albicans and non-Candida albicans species. BioMed Res. Int. 2021, 5598907 (2021).","journal-title":"BioMed Res. Int."},{"key":"59824_CR21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/EC.00194-06","volume":"5","author":"CJ Nobile","year":"2006","unstructured":"Nobile, C. J., Nett, J. E., Andes, D. R. & Mitchell, A. P. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 5, 1604\u20131610 (2006).","journal-title":"Eukaryot. Cell"},{"key":"59824_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11046-008-9148-6","volume":"167","author":"H Nailis","year":"2009","unstructured":"Nailis, H. et al. Monitoring ALS1 and ALS3 gene expression during in vitro Candida albicans biofilm formation under continuous flow conditions. Mycopathologia 167, 9\u201317 (2009).","journal-title":"Mycopathologia"},{"key":"59824_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.55133\/eji.290413","volume":"29","author":"M El Said","year":"2022","unstructured":"El Said, M. et al. Detection of ERG11 gene in fluconazole resistant urinary candida isolates. Egypt. J. Immunol. 29, 134\u2013147 (2022).","journal-title":"Egypt. J. Immunol."},{"key":"59824_CR24","unstructured":"bioM\u00e9rieux. VITEK\u00ae 2\u2014Clinical Products. (2023)."},{"key":"59824_CR25","doi-asserted-by":"publisher","unstructured":"Preparation of routine media and reagents used in antimicrobial susceptibility testing. In Clinical Microbiology Procedures Handbook (ed. Leber, A. L.) 5.20.1.1\u20135.20.3.10 (ASM Press, Washington, DC, USA, 2016). https:\/\/doi.org\/10.1128\/9781555818814.ch5.20.1.","DOI":"10.1128\/9781555818814.ch5.20.1"},{"key":"59824_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.06.014","volume":"95","author":"M Hacioglu","year":"2019","unstructured":"Hacioglu, M., Haciosmanoglu, E., Birteksoz-Tan, A. S., Bozkurt-Guzel, C. & Savage, P. B. Effects of ceragenins and conventional antimicrobials on Candida albicans and Staphylococcus aureus mono and multispecies biofilms. Diagn. Microbiol. Infect. Dis. 95, 114863 (2019).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"59824_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103768","volume":"137","author":"D-S Shin","year":"2019","unstructured":"Shin, D.-S. & Eom, Y.-B. Efficacy of zerumbone against dual-species biofilms of Candida albicans and Staphylococcus aureus. Microb. Pathog. 137, 103768 (2019).","journal-title":"Microb. Pathog."},{"key":"59824_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/microorganisms7030073","volume":"7","author":"L Corte","year":"2019","unstructured":"Corte, L., Casagrande Pierantoni, D., Tascini, C., Roscini, L. & Cardinali, G. Biofilm specific activity: A measure to quantify microbial biofilm. Microorganisms 7, 73 (2019).","journal-title":"Microorganisms"},{"key":"59824_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134 (2012).","journal-title":"BMC Bioinformatics"},{"key":"59824_CR30","unstructured":"Qiagen. miRNeasy Mini Kit: Quick-Start Protocol. (2016)."},{"key":"59824_CR31","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.2147\/IDR.S228981","volume":"12","author":"M Amin","year":"2019","unstructured":"Amin, M. et al. Association between biofilm formation, structure, and the expression levels of genes related to biofilm formation and biofilm-specific resistance of Acinetobacter baumannii strains isolated from burn infection in Ahvaz. Iran. Infect. Drug Resist. 12, 3867\u20133881 (2019).","journal-title":"Iran. Infect. Drug Resist."},{"key":"59824_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3390\/jof9030355","volume":"9","author":"A Maione","year":"2023","unstructured":"Maione, A. et al. Anti-biofilm activity of phenyllactic acid against clinical isolates of fluconazole-resistant Candida albicans. J. Fungi 9, 355 (2023).","journal-title":"J. Fungi"},{"key":"59824_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107, S. et al. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115, 891\u2013899 (2007).","journal-title":"APMIS"},{"key":"59824_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"59824_CR35","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing. (Clinical and Laboratory Standards Institute, Place of publication not identified, 2021)."},{"key":"59824_CR36","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/antibiotics11121731","volume":"11","author":"VT Anju","year":"2022","unstructured":"Anju, V. T. et al. Polymicrobial infections and biofilms: Clinical significance and eradication strategies. Antibiotics 11, 1731 (2022).","journal-title":"Antibiotics"},{"key":"59824_CR37","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.3349\/ymj.2017.58.6.1135","volume":"58","author":"K-H Lee","year":"2017","unstructured":"Lee, K.-H., Park, S. J., Choi, S. J. & Park, J. Y. Proteus vulgaris and Proteus mirabilis decrease Candida albicans Biofilm formation by suppressing morphological transition to its hyphal form. Yonsei Med. J. 58, 1135 (2017).","journal-title":"Yonsei Med. J."},{"key":"59824_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5455\/jabet.2023.d108","volume":"6","author":"D Asih","year":"2023","unstructured":"Asih, D. et al. Biofilm formation by the interaction of fungi (Candida tropicalis) with various bacteria. J. Adv. Biotechnol. Exp. Ther. 6, 84 (2023).","journal-title":"J. Adv. Biotechnol. Exp. Ther."},{"key":"59824_CR39","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1128\/IAI.00096-09","volume":"77","author":"JA Gaddy","year":"2009","unstructured":"Gaddy, J. A., Tomaras, A. P. & Actis, L. A. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect. Immun. 77, 3150\u20133160 (2009).","journal-title":"Infect. Immun."},{"key":"59824_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/AAC.01540-15","volume":"60","author":"X Kostoulias","year":"2016","unstructured":"Kostoulias, X. et al. Impact of a cross-kingdom signaling molecule of Candida albicans on Acinetobacter baumannii physiology. Antimicrob. Agents Chemother. 60, 161\u2013167 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59824_CR41","doi-asserted-by":"publisher","DOI":"10.53730\/ijhs.v6nS3.8132","author":"T Tannupriya","year":"2022","unstructured":"Tannupriya, T., Kapoor, D. & Garg, V. K. Antifungal drugs susceptibility towards candida albicans in female patients with UTI. Int. J. Health Sci. https:\/\/doi.org\/10.53730\/ijhs.v6nS3.8132 (2022).","journal-title":"Int. J. Health Sci."},{"key":"59824_CR42","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1038\/s41598-024-61813-w","volume":"14","author":"AM Dawoud","year":"2024","unstructured":"Dawoud, A. M., Saied, S. A., Torayah, M. M., Ramadan, A. E. & Elaskary, S. A. Antifungal susceptibility and virulence determinants profile of candida species isolated from patients with candidemia. Sci. Rep. 14, 11597 (2024).","journal-title":"Sci. Rep."},{"key":"59824_CR43","doi-asserted-by":"publisher","first-page":"22068","DOI":"10.1038\/s41598-024-73258-2","volume":"14","author":"H-L Zhang","year":"2024","unstructured":"Zhang, H.-L. et al. Analysis of antimicrobial resistance and genetic diversity of Acinetobacter baumannii in a tertiary care hospital in Haikou City. Sci. Rep. 14, 22068 (2024).","journal-title":"Sci. Rep."},{"key":"59824_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jof6010005","volume":"6","author":"ME Rodrigues","year":"2019","unstructured":"Rodrigues, M. E., Gomes, F. & Rodrigues, C. F. Candida spp.\/bacteria mixed biofilms. J. Fungi 6, 5 (2019).","journal-title":"J. Fungi"},{"key":"59824_CR45","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1128\/AAC.00657-09","volume":"53","author":"MM Harriott","year":"2009","unstructured":"Harriott, M. M. & Noverr, M. C. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: Effects on antimicrobial resistance. Antimicrob. Agents Chemother. 53, 3914\u20133922 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59824_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007056","volume":"14","author":"P Uppuluri","year":"2018","unstructured":"Uppuluri, P. et al. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection. PLOS Pathog. 14, e1007056 (2018).","journal-title":"PLOS Pathog."},{"key":"59824_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.953168","volume":"12","author":"MB Atiencia-Carrera","year":"2022","unstructured":"Atiencia-Carrera, M. B. et al. Evaluation of the biofilm life cycle between Candida albicans and Candida tropicalis. Front. Cell. Infect. Microbiol. 12, 953168 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"59824_CR48","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/IDR.S169894","volume":"11","author":"E Eze","year":"2018","unstructured":"Eze, E., Chenia, H. & El Zowalaty, M. Acinetobacter baumannii biofilms: Effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect. Drug Resist. 11, 2277\u20132299 (2018).","journal-title":"Infect. Drug Resist."},{"key":"59824_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmic.2023.100084","volume":"16","author":"P Shree","year":"2023","unstructured":"Shree, P., Singh, C. K., Sodhi, K. K., Surya, J. N. & Singh, D. K. Biofilms: Understanding the structure and contribution towards bacterial resistance in antibiotics. Med. Microecol. 16, 100084 (2023).","journal-title":"Med. Microecol."},{"key":"59824_CR50","first-page":"1731","volume":"11","author":"VT Anju","year":"2022","unstructured":"Anju, V. T. et al. Polymicrobial infections and biofilms: Clinical significance and eradication strategies. Antibiot. Basel Switz. 11, 1731 (2022).","journal-title":"Antibiot. Basel Switz."},{"key":"59824_CR51","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1128\/AAC.02180-15","volume":"60","author":"X Tan","year":"2016","unstructured":"Tan, X. et al. Candida albicans airway colonization facilitates subsequent Acinetobacter baumannii pneumonia in a rat model. Antimicrob. Agents Chemother. 60, 3348\u20133354 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"59824_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.655242","volume":"12","author":"K Deng","year":"2021","unstructured":"Deng, K. et al. ALS3 expression as an indicator for Candida albicans biofilm formation and drug resistance. Front. Microbiol. 12, 655242 (2021).","journal-title":"Front. Microbiol."},{"key":"59824_CR53","doi-asserted-by":"publisher","first-page":"14585","DOI":"10.1073\/pnas.0805048105","volume":"105","author":"AY Peleg","year":"2008","unstructured":"Peleg, A. Y. et al. Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 105, 14585\u201314590 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"59824_CR54","doi-asserted-by":"publisher","first-page":"e1000834","DOI":"10.1371\/journal.ppat.1000834","volume":"6","author":"L Camarena","year":"2010","unstructured":"Camarena, L., Bruno, V., Euskirchen, G., Poggio, S. & Snyder, M. Molecular mechanisms of ethanol-induced pathogenesis revealed by RNA-sequencing. PLoS Pathog. 6, e1000834 (2010).","journal-title":"PLoS Pathog."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59824-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59824-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:02:30Z","timestamp":1783692150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59824-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59824"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59824-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Mansoura Faculty of Medicine in Mansoura University (Code Number: MS.25.11.3375). The requirement for informed consent to participate was waived by the IRB because the study used anonymized clinical isolates with no direct involvement of human participants, in accordance with national regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not contain any data for any individual.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"21635"}}